# Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-patterns-of-response-and-recurrence-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard Zuniga,Roy Torcuator,Rajan Jain,John E. Anderson,Thomas J. Doyle,Shehanaz Ellika,L. Schultz,T. Mikkelsen |
| Citations | 275 |
| DOI | 10.1007/s11060-008-9718-y |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2140201170 |
| PMID | 18953493 |
| Type | article |
| Year | 2008 |

## Paper authors

- [John E. Anderson](https://scholariq.org/researchers/john-e-anderson/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.